Maggie Powers

Maggie Powers

Auto-generated profile, based on publicly available information

Maggie Powers

Division of Thoracic Surgery, Department of Surgery, UMass Memorial Healthcare /University of Massachusetts Medical School, 67 Belmont Street #201, Worcester, MA, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
IEIsabel Cristina Martins Emmerick
Isabel Cristina Martins Emmerick
ASAnupama Singh
Anupama Singh
MPMaggie Powers
Maggie Powers
FLFeiran Lou
Feiran Lou
PLPoliana Lin
Poliana Lin
KUKarl Uy
Karl Uy
OBJECTIVE To present the overall survival rate for lung cancer and identify the factors associated with early diagnosis of stage I and II lung cancer. METHODS This is a retrospective cohort study including individuals diagnosed with lung cancer, from January 2009 to December 2017, according to the cancer registry at UMass Memorial Medical Center. Five-year overall survival and its associated factors were identified by Kaplan–Meier curves and Cox’s proportional hazards model. Factors associated with diagnosing clinical stage I and II lung cancer were identified by bivariate and multivariate backward stepwise logistic regression (Log-likelihood ratio (LR)) at 95% confidence interval (CI). RESULTS The study was conducted with data on 2730 individuals aged 67.9 years on average, 51.5% of whom female, 92.3% white, and 6.6% never smoked. Five-year overall survival was 21%. Individuals diagnosed with early-stage disease had a 43% five-year survival rate compared to 8% for those diagnosed at late stages. Stage at diagnosis was the main factor associated with overall survival [HR = 4.08 (95%CI: 3.62–4.59)]. Factors associated with early diagnosis included patients older than 68 years [OR = 1.23 (95%CI: 1.04–1.45)], of the female gender [OR = 1.47 (95%CI: 1.24–1.73)], white [OR = 1.63 (95%CI: 1.16–2.30)], and never-smokers [OR = 1.37 (95%CI: 1.01–1.86)]; as well as tumors affecting the upper lobe [OR = 1.46 (95%CI: 1.24–1.73)]; adenocarcinoma [OR = 1.43 (95%CI: 1.21–1.69)]; and diagnosis after 2014 [OR = 1.61 (95%CI: 1.37–1.90)]. CONCLUSIONS Stage at diagnosis was the most decisive predictor for survival. Non-white and male individuals were more likely to be diagnosed at a late stage. Thus, promoting lung cancer early diagnosis by improving access to health care is vital to enhance overall survival for individuals with lung cancer.

1 March 2022 in Journal of Cancer Policy
Verified
Journal Article
Closed access
IEIsabel Cristina Martins Emmerick
Isabel Cristina Martins Emmerick
KUKarl Uy
Karl Uy
KGKeren Guiab
Keren Guiab
MPMaggie Powers
Maggie Powers
FLFeiran Lou
Feiran Lou
JVJohn Varlotto
John Varlotto